Antagonism by antimuscarinic and ganglion-blocking drugs of some of the behavioural effects of nicotine.
D000109:Acetylcholine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002714:Chlorisondamine / Q000008:administration & dosage / Q000494:pharmacology; D003216:Conditioning, Operant / Q000187:drug effects*; D005730:Ganglionic Blockers / Q000494:pharmacology*; D008297:Male; D008464:Mecamylamine / Q000008:administration & dosage / Q000494:pharmacology; D009538:Nicotine / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D010276:Parasympatholytics / Q000494:pharmacology*; D011680:Pupil / Q000187:drug effects; D051381:Rats; D012601:Scopolamine / Q000008:administration & dosage / Q000494:pharmacology
D005730:Ganglionic Blockers; D010276:Parasympatholytics; D008464:Mecamylamine; D009538:Nicotine; D001285:Atropine; D012601:Scopolamine; D002714:Chlorisondamine; D000109:Acetylcholine